BSE Live
Nov 07, 16:01Prev. Close
264.40
Open Price
266.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:55Prev. Close
264.45
Open Price
265.00
Bid Price (Qty.)
260.95 (516)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Indoco Remedies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 860.11 | 730.10 | 637.67 | 567.58 | 484.15 | |
| Less: Excise/Sevice Tax/Other Levies | 11.21 | 12.74 | 11.24 | 7.45 | 5.09 | |
| Revenue From Operations [Net] | 848.89 | 717.37 | 626.43 | 560.13 | 479.06 | |
| Total Operating Revenues | 853.63 | 727.71 | 630.40 | 568.77 | 481.07 | |
| Other Income | 1.74 | 1.75 | 0.90 | 2.26 | 2.88 | |
| Total Revenue | 855.38 | 729.46 | 631.29 | 571.04 | 483.95 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 264.07 | 230.16 | 223.29 | 222.71 | 188.48 | |
| Purchase Of Stock-In Trade | 53.63 | 40.05 | 35.54 | 33.65 | 31.98 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -19.25 | -1.05 | 3.13 | -11.38 | -11.90 | |
| Employee Benefit Expenses | 139.36 | 129.05 | 100.31 | 81.90 | 67.27 | |
| Finance Costs | 10.34 | 18.80 | 21.88 | 16.33 | 0.52 | |
| Depreciation And Amortisation Expenses | 47.11 | 30.91 | 23.72 | 19.25 | 13.45 | |
| Other Expenses | 250.63 | 209.43 | 175.05 | 157.31 | 137.55 | |
| Total Expenses | 745.89 | 657.36 | 582.92 | 519.77 | 427.36 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 109.48 | 72.11 | 48.37 | 51.27 | 56.58 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 109.48 | 72.11 | 48.37 | 51.27 | 56.58 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 30.61 | 15.11 | 9.68 | 10.26 | 11.28 | |
| Less: MAT Credit Entitlement | 2.99 | 0.00 | 9.68 | 9.00 | 7.28 | |
| Deferred Tax | -3.51 | -4.28 | 5.43 | 3.66 | 1.47 | |
| Tax For Earlier Years | 2.56 | 3.38 | 0.28 | 0.00 | 0.00 | |
| Total Tax Expenses | 26.67 | 14.21 | 5.71 | 4.92 | 5.47 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 82.81 | 57.90 | 42.66 | 46.34 | 51.12 | |
| Profit/Loss From Continuing Operations | 82.81 | 57.90 | 42.66 | 46.34 | 51.12 | |
| Profit/Loss For The Period | 82.81 | 57.90 | 42.66 | 46.34 | 51.12 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 8.99 | 6.28 | 4.63 | 37.72 | 41.60 | |
| Diluted EPS (Rs.) | 8.99 | 6.28 | 4.63 | 37.72 | 41.60 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 58.15 | 38.38 | 28.01 | 36.42 | 37.07 | |
| Indigenous Raw Materials | 205.92 | 191.79 | 195.28 | 186.28 | 151.41 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 1.22 | 0.79 | 0.16 | 0.18 | 0.02 | |
| Indigenous Stores And Spares | 0.33 | 0.35 | 1.25 | 1.49 | 1.86 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 14.74 | 12.90 | 10.14 | 10.14 | 9.83 | |
| Tax On Dividend | 3.00 | 2.19 | 1.72 | 1.64 | 1.59 | |
| Equity Dividend Rate (%) | 80.00 | 70.00 | 55.00 | 55.00 | 80.00 |
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
27.05.2025
Indoco Remedies Consolidated March 2025 Net Sales at Rs 390.21 crore, down 13.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher